Study to determine the seroconversion rate following measles vaccination.

Show simple item record

dc.contributor.author Gunawardana, S
dc.date.accessioned 2011-12-06T08:52:51Z
dc.date.available 2011-12-06T08:52:51Z
dc.date.issued 1994
dc.identifier.citation MD (Medical Microbiology) en_US
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/892
dc.description.abstract Global goals for measles reduction was set at reducing measles cases and measles death by 90 per cent and 95 per cent respectively by the end of 1995.To achieve this goal, all countries had to achieve over 90 per cent vaccination coverage. In Sri Lanka immunization coverage against measles for the first quarter of 1996 was 89.6 percent. With such a high coverage and a serocon version rate of 93.06 per cent, it is hoped that measles would soon become a rare disease in Sri Lanka
dc.language.iso en en_US
dc.title Study to determine the seroconversion rate following measles vaccination. en_US
dc.type Research abstract en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account